ENG and breast adenocarcinoma: For in vivo experiments on silencing of endoglin in tumor endothelial cells, the murine TS/A mammary adenocarcinoma growing in immunocompetent BALB/c mice was used, since the TS/A cells themselves express almost undetectable levels of endoglin mRNA and our aim was to target support cells within the tumors.